Luckwel Pharmaceuticals, Inc. is a shell company, which intends to engage in the pharmaceutical operations in Waltham/Boston, focusing on hypertension candidate drug (KL-008) and rheumatoid arthritis candidate drug (KL-009). The company was founded on January 2, 2013 and is headquartered in Boston, MA.
Company profile
Ticker
LWEL
Exchange
CEO
Kingrich J. Lee
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
LUCKYCOM INC, Luckycom Pharmaceuticals Inc.
SEC CIK
LWEL stock data
Latest filings (excl ownership)
8-K
Entry into a Material Definitive Agreement
1 Oct 21
8-K/A
Changes in Registrant's Certifying Accountant
22 Sep 21
8-K
Changes in Registrant's Certifying Accountant
21 Sep 21
10-K
2021 FY
Annual report
9 Sep 21
10-Q
2021 Q3
Quarterly report
8 Sep 21
10-Q
2021 Q2
Quarterly report
8 Sep 21
10-Q
2021 Q1
Quarterly report
7 Sep 21
10-K
2020 FY
Annual report
10 Jun 21
8-K
Entry into a Material Definitive Agreement
26 May 21
8-K
Entry into a Material Definitive Agreement
27 Apr 21
Latest ownership filings
No filings
Financial summary
Quarter (USD) | Mar 21 | Dec 20 | Sep 20 | Jun 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Mar 21 | Mar 20 | Mar 19 | Mar 18 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 2.04 k | 2.04 k | 2.04 k | 2.04 k | 2.04 k | 2.04 k |
Cash burn (monthly) | 358.33 | (no burn) | 71.59 k | 36.25 k | 52.02 k | 16.50 k |
Cash used (since last report) | 13.13 k | n/a | 2.62 mm | 1.33 mm | 1.91 mm | 604.41 k |
Cash remaining | -11.08 k | n/a | -2.62 mm | -1.33 mm | -1.90 mm | -602.36 k |
Runway (months of cash) | -30.9 | n/a | -36.6 | -36.6 | -36.6 | -36.5 |